Home » Galderma Wins FDA Approval for Vectical Ointment
Galderma Wins FDA Approval for Vectical Ointment
February 3, 2009
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration (FDA) has approved Vectical (calcitriol) Ointment 3mcg/g, a unique vitamin D3 product for the treatment of mild-to-moderate plaque psoriasis in adults.
The Earth Times
The Earth Times
Upcoming Events
-
21Oct